Expression of inducible microsomal prostaglandin E synthase in local lesions of endometriosis patients

American Journal of Reproductive Immunology

Volumn 57, Issue 3, 2007, Pages 218-226

  Chishima, Fumihisa ^a   Hayakawa, Satoshi ^a   Yamamoto, Tatsuo ^a   Sugitani, Masahiko ^a   Karasaki Suzuki, Miki ^a   Sugita, Kenji ^a   Nemoto, Norimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometriosis; Microsomal prostaglandin E synthase; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME ANALYSIS; ENZYME SYNTHESIS; EPITHELIUM CELL; FEMALE; FROZEN SECTION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MALIGNANT TRANSFORMATION; MICROSOME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STROMA CELL;

ADULT; CYCLOOXYGENASE 2; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MEMBRANE PROTEINS; MENSTRUAL CYCLE; MICROSOMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 33846899243     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00466.x     Document Type: Article

References (38)

1. Taylor RN, Lundeen SG, Giudice LC: Emerging role of genomics in endometriosis research. Fertil Steril 2002; 78: 694-698.
2. D'Hooghe TM, Hill JA: Endometriosis. In Novak's Gynecology, 13th edn, JS Berek (ed). Philadelphia, PA, Williams and Wilkins, 2002, pp 931-972.
3. Vernon MN, Beard JS, Graves K, Wilson EA: Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F. Fertil Steril 1986; 46: 801-806.
4. Darke TS, O'Brien WF, Ramwell PW, Mets SA: Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F2α in endometriosis. Am J Obstet Gynecol 1981; 140: 401-409.
5. Van Voolhis BJ, Huettner PC, Clark MR, Hill HA: Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis. Am J Obstet Gynecol 1990; 163: 57-623.
6. Badawy SZA, Marshall L, Cuenca V: Peritoneal fluid prostaglandins in various stages of the menstrual cycle: Role in infertile patients with endometriosis. Int J Fertil 1985; 30: 48-52.
7. Ota H, Igarashi S, Sasaki M, Tanaka T: Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001; 16: 561-566.
8. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Sheike Aleemuzzaman ??, Nemoto N, Yamamoto T, Honda M: Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002; 48: 50-56.
9. Tsujii M, DuBois RN: Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
10. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B: Identification of human prostaglandin E synthase: A microsomal glutathione-dependent, inducible enzyme constituting a potential novel drug target. Proc Natl Acad Sci U S A 1999; 96: 7220-7225.
11. Yoshimatsu K, Golijanin D, Paty PB, Soslow RA, Jakobsson PJ, DeLellis RA, Subbaramaiah K, Dannenberg AJ. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 2001; 7: 3971-3976.
12. van Rees BP, Sivula A, Thoren S, Yokozaki H, Jakobsson PJ, Offerhaus JA, Ristimaki A: Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int J Cancer 2003; 107: 551-556.
13. Jabbour HN, Milne SA, Williams ARW, Anderson RA, Boddy SC: Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: A possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer 2001; 85: 1023-1031.
14. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T, Fueki M, Ueno A, Oh-ishi S, Kudo I: Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000; 275: 32783-32792.
15. Kino Y, Kojima F, Kiguchi K, Igarashi R, Ishizuka B, Kawai S: Prostaglandin E2 production in ovarian cancer cell line is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 103-111.
16. Hla T., Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992; 89: 7384-7388.
17. Adcock IM, Brown CR, Kwon O, Barnes PJ: Oxidative stress induces NF κ B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199: 1518-1524.
18. Forsberg L, Leeb L, Thoren S, Morgenstern R, Jakobsson P-J: Human glutathione dependent prostaglandin E synthase: Gene structure and regulation. FEBS Lett 2000; 471: 78-82.
19. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ: Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999; 274: 10911-10915.
20. Mayr D, Amann G, Siefert C, Diebold J, Anderegg B: Does endometriosis really have premalignant potential? A clonal analysis of laser-microdissected tissue. FASEB J 2003; 17: 693-695.
21. Wu Y, Basir Z, Kajdacsy-Balla A, Strawn E, Macias V, Montgomery K, Guo SW: Resolution of clonal origins for endometriotic lesion using laser capture microdissection and human androgen receptor (HUMARA) assay. Fertil Steril 2003; 79: 3-7.
22. Tamura M, Fukaya T, Murakami T, Uehara S, Yajima A: Analysis of clonality in human endometriotic cysts based on evaluation of X chromosome inactivation in archival formalin-fixed, paraffin-embedded tissue. Lab Invest 1998; 78: 213-218.
23. Jimbo H, Hitomi Y, Yoshikawa H, Yano T, Momoeda M, Sakamoto A, Tsutsumi O, Taketani Y: Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am J Pathol 1997; 150: 1173-1178.
24. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci 2002; 955: 281-292.
25. Clement PB, Seidman JD, Russell P, Kurman RJ: In Blaustein's Pathology of Female Genital Tract, 5th edn, Kurman RJ (ed). New York, Springer, 2002, pp 746-768, 791-905.
26. Denkert C, Kobel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B, Hauptmann S: Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002; 160: 893-903.
27. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF: Cyclooxygenase-2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998; 115: 297-306.
28. McCartney SA, Mitchell JA, Fairclough PD, Farthing MJG, Warner TD: Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment Pharmacol Ther 1999; 13: 1115-1117.
29. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng G., Ferrara N, Jaffe RB, Taylor RN: Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81: 3112-3118.
30. Gupta RA, Tejada LV, Tong BJ, Das SK, Morrow JD, Dey SK, DuBois RN: Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res 2003; 63: 906-911.
31. Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, Huang M, Dohadwala M, Batra RK, Dubinett SM: Tumor cyclooxygenase-2 dependent suppression of dendritic cell function. Clin Cancer Res 2003; 9: 961-968.
32. Wub CY, Wang K, McDyer JF, Seder RA: Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol 1998; 161: 2723-2730.
33. Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Bsron JA.: Risk of cancer in a large cohort of nonaspirin NSAID users: A population-based study. Br J Cancer 2003; 88: 1687-1692.
34. Tavani A, Gallus S, La Vecchia C, Conti E, Montella M, Franceschi: aspirin and ovarian cancer: An Italian case-control study. Ann Oncol 2000; 11: 1171-1173.
35. Efstathiou JA, Sampson DA, Levine Z, Rohan RM, Zurakowski D, Folkman J, D'Amato RJ, Rupnick MA: Nonsteroidal anti-inflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril 2005; 83: 171-181.
36. Cobellis L, Razzi S, De Simone S, Sartini A, Fava A, Danero S, Gioffre W, Mazzini M, Petraglia F: The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol 2004; 116: 100-102.
37. Matsuzaki S, Canis M, Darcha C, Dallel R, Okamura K, Mage G: Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 2004; 82: 1609-1615.
38. Ozawa Y, Murakami T, Tamura M, Terada Y, Yaegashi N, Okamura K: A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril 2006; 86: 1146-1151.